Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000038681 | SCV000062359 | benign | not specified | 2012-03-19 | criteria provided, single submitter | clinical testing | p.Pro4Leu in Exon 01 of NEBL: This variant is not expected to have clinical sign ificance because it has been identified in 1.3% (49/3738) of African American ch romosomes from a broad population by the NHLBI Exome Sequencing Project (http:// evs.gs.washington.edu/EVS; dbSNP rs114918858). |
Eurofins Ntd Llc |
RCV000038681 | SCV000224517 | benign | not specified | 2015-04-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000038681 | SCV000236074 | benign | not specified | 2014-08-13 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000229625 | SCV000289516 | benign | Primary dilated cardiomyopathy | 2025-01-31 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000038681 | SCV004038163 | likely benign | not specified | 2023-08-19 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004717921 | SCV005320543 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003944920 | SCV004772607 | benign | NEBL-related disorder | 2019-02-21 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |